Spanish Generic Medicines Association

Who is AESEG

AESEG is the official representative body of the generic pharmaceutical industry in Spain

Generic Medicines Definitions

A generic medicine has the same composition and the same pharmaceutical form as an original medicine

Generics in Spain

Generic medicines in Spain are still far away from the European average

Studies and Reports about Generics Medicines

Studies and Reports about Generics Medicines

Upcoming Events

II FORO HISPANO-LUSO DE LA FARMACIA. MEDICAMENTOS GENÉRICOS, APUESTA COMPARTIDA

II FORO HISPANO-LUSO DE LA FARMACIA. MEDICAMENTOS GENÉRICOS, APUESTA COMPARTIDA

Madrid, 23 de mayo de 2017

Leer más
37 SYMPOSIUM AEFI

37 SYMPOSIUM AEFI

Barcelona, 7 - 8 de junio de 2017

Leer más
Jornada “Consumer Health: Novedades y Compromisos del Canal Farmacia”

Jornada “Consumer Health: Novedades y Compromisos del Canal Farmacia”

Madrid, 8 de junio de 2017

Leer más
Joint 23rd Medicines for Europe and 20th IGBA Annual Conference

Joint 23rd Medicines for Europe and 20th IGBA Annual Conference

Lisboa, 14 - 16 de junio de 2017

Leer más

 

En generico Magazine Nº 26

GENERICS IN THE SENATE ARROWED BY THE SECTOR

The celebration, at the headquarters of the Senate, of an institutional meeting chaired by the president of the Senate and by the general director of the Basic Portfolio of Services of the National Health and Pharmacy System of the Ministry of Health, where debate was held on the past, the present and the future of generic medicines in particular, and the pharmaceutical industry that develops them, produces and markets them in general, has marked a milestone for the sector, both because of the framework in which it has taken place and because for its participants.

Read more

 

Revista en genérico Nº 26 - LOS GENÉRICOS EN EL SENADO ARROPADOS POR EL SECTOR

En generico Blog 

For your health, for the health of all of us

Blog aimed at anyone who wants to express opinions through comments, suggestions and articles of collaborations.
We offer everyone, this place to spread more rigorous knowledge of the generic medicines in the Spanish society.


Read more

Medicines for Europe: vision

Patients

We create enhanced access to medicines, reducing inequalities, directly leading to improved patient outcomes. We compete, stimulating the medicines industry to innovate. We innovate, enriching patient benefit.

 

Quality

We provide a stable and resilient supply of high-quality medicines, manufactured and developed according to stringent EU regulatory requirements, for Europe’s patients and healthcare providers.

Value

Our high-quality cost-effective medicines account for well over 54% of all prescription medicines used to treat European patients. We are the heart of public health delivery in Europe. We generate cost savings of more than €35bn each year ensuring the viability of Europe’s healthcare systems and enable them to invest in new medicines and other treatments that Europe’s patients increasingly need.

Sustainability

Use of our medicines supports the economic sustainability of Europe’s healthcare systems. We contribute to Europe’s economies, researching, developing and manufacturing in most European countries the majority of medicines used in the EU, sustaining more than 150.000 high skilled, high value direct jobs. As a leading knowledge based industry we will continue to work with Europe’s policy makers, legislators and regulators to create the right environment to support and strengthen the economic sustainability of our industry so that we can continue to contribute to European patients and society.

Partnership

We build constructive partnerships, focused on a strong and stable collaboration with patients and patient organisations, the EU institutions, governments and regulators, healthcare professionals and others to further enhance public health in Europe.

Medicines for Europe
  • footer_logo
  •   Velázquez, 54 - 3º - 28001 - Madrid - España
  •   +34 91 572 12 62
  •   +34 91 571 34 20
  • aeseg@aeseg.es
  • AESEG es miembro de:
  •   
  •   

Search


@AESEG_genericos

AESEG_genericos Las bacterias multirresistentes causan 25.000 muertes al año en Europa y alrededor de 2.800 en España. ¿Cómo podemo… twitter.com/i/web/status/1…

6 hours ago. via Hootsuite • 2 retweets

AESEG_genericos #20AñosGenéricos Belén Crespo (@AEMPSGOB): "Tenemos una buena industria del genérico, mejor no me la imagino" pic.twitter.com/xFGE8zAnI3

10 hours ago. via Hootsuite

Flickr AESEG